Gene · 11096
Papers3,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Progress in regulating inflammatory biomaterials for intervertebral disc regeneration. | Bioact Mater | 2024 | 38162512 | PubTator, text mining | PubMed |
| The protective effect of Ergolide in osteoarthritis: In vitro and in vivo studies. | Int Immunopharmacol | 2024 | 38157693 | PubTator, text mining | PubMed |
| DNA demethylation of promoter region orchestrates SPI-1-induced ADAMTS-5 expression in articular cartilage of osteoarthritis mice. | J Cell Physiol | 2024 | 38149721 | PubTator, text mining | PubMed |
| Paeoniflorin, the Main Monomer Component of Paeonia lactiflora, Exhibits Anti-inflammatory Properties in Osteoarthritis Synovial Inflammation. | Chin J Integr Med | 2024 | 37999887 | PubTator, text mining | PubMed |
| Single‑cell sequencing, genetics, and epigenetics reveal mesenchymal stem cell senescence in osteoarthritis (Review). | Int J Mol Med | 2024 | 37937669 | PubTator, text mining | PubMed |
| Reprogramming macrophages via immune cell mobilized hydrogel microspheres for osteoarthritis treatments. | Bioact Mater | 2024 | 37869722 | PubTator, text mining | PubMed |
| Supramolecular self-assembly of EGCG-selenomethionine nanodrug for treating osteoarthritis. | Bioact Mater | 2024 | 37822916 | PubTator, text mining | PubMed |
| Piezo1 activation accelerates osteoarthritis progression and the targeted therapy effect of artemisinin. | J Adv Res | 2024 | 37758057 | PubTator, text mining | PubMed |
| Pathogenic Mechanisms and Therapeutic Approaches in Obesity-Related Knee Osteoarthritis. | Biomedicines | 2023 | 38275369 | PubTator, text mining | PubMed |
| Endogenous retroviruses Suppressyn and Syncytin-2 as innovative prognostic biomarkers in Acute Myeloid Leukemia. | Front Cell Infect Microbiol | 2023 | 38274728 | PubTator, text mining | PubMed |
| Biological functions and applications of LncRNAs in the regulation of the extracellular matrix in osteoarthritis. | Front Cell Dev Biol | 2023 | 38259516 | PubTator, text mining | PubMed |
| Chemokines in Cartilage Regeneration and Degradation: New Insights. | Int J Mol Sci | 2023 | 38203552 | PubTator, text mining | PubMed |
| Osteoarthritis in the Elderly Population: Preclinical Evidence of Nutrigenomic Activities of Flavonoids. | Nutrients | 2023 | 38201942 | PubTator, text mining | PubMed |
| Stem cells and pain. | World J Stem Cells | 2023 | 38179216 | PubTator, text mining | PubMed |
Transcription Analysis of the THBS2 Gene through Regulation by Potential Noncoding Diagnostic Biomarkers and Oncogenes of Gastric Cancer in the ECM-Receptor Interaction Signaling Pathway: Integrated System Biology and Experimental Investigation. | Int J Genomics | 2023 | 38162289 | PubTator, text mining | PubMed |
Evaluating the potential of Vitamin D and curcumin to alleviate inflammation and mitigate the progression of osteoarthritis through their effects on human chondrocytes: A proof-of-concept investigation. | PLoS One | 2023 | 38157375 | PubTator, text mining | PubMed |
| Biomarkers for intervertebral disc and associated back pain: From diagnosis to disease prognosis and personalized treatment. | JOR Spine | 2023 | 38156062 | PubTator, text mining | PubMed |
| Cartilaginous endplates: A comprehensive review on a neglected structure in intervertebral disc research. | JOR Spine | 2023 | 38156054 | PubTator, text mining | PubMed |
| In Vitro Chondrogenesis Induction by Short Peptides of the Carboxy-Terminal Domain of Transforming Growth Factor β1. | Biomedicines | 2023 | 38137403 | PubTator, text mining | PubMed |
| Anti-Osteoarthritis Mechanism of the Nrf2 Signaling Pathway. | Biomedicines | 2023 | 38137397 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11096/papers?page=13